[HTML][HTML] Genetic and molecular aspects of drug-induced QT interval prolongation

D Baracaldo-Santamaría, K Llinás-Caballero… - International Journal of …, 2021 - mdpi.com
Long QT syndromes can be either acquired or congenital. Drugs are one of the many
etiologies that may induce acquired long QT syndrome. In fact, many drugs frequently used …

Drug response in association with pharmacogenomics and pharmacomicrobiomics: towards a better personalized medicine

R Hassan, I Allali, FE Agamah… - Briefings in …, 2021 - academic.oup.com
Researchers have long been presented with the challenge imposed by the role of genetic
heterogeneity in drug response. For many years, Pharmacogenomics and …

[PDF][PDF] Молекулярно-генетические аспекты лекарственно-индуцированного синдрома удлиненного интервала QT

ЛВ Колоцей, ВА Снежицкий - Кардиология в Беларуси, 2021 - scholar.archive.org
Синдром удлиненного интервала QT (СУИ QT) может быть как врожденным, так и
приобретенным, причем последний наиболее часто вызывается воздействием …

QTc interval prolongation with therapies used to treat patients with Parkinson's disease psychosis: a narrative review

Y Torres-Yaghi, A Carwin, J Carolan… - Neuropsychiatric …, 2021 - Taylor & Francis
In addition to the classic motor symptoms of Parkinson's disease (PD), people with PD
frequently experience nonmotor symptoms that can include autonomic dysfunction and …

Emerging Roles of the Human Solute Carrier 22 Family.

K Giacomini, SW Yee - Drug Metabolism and Disposition, 2021 - escholarship.org
The human Solute Carrier 22 family (SLC22), also termed the organic ion transporter family,
consists of 28 distinct multi-membrane spanning proteins, which phylogenetically cluster …

Estudio de las bases genéticas de las cardiopatías familiares y las arritmias inducidas por fármacos

M Martínez Matilla - 2021 - minerva.usc.es
En la presente tesis doctoral, se aborda el estudio del componente genético que subyace
en las cardiopatías familiares, íntimamente relacionadas con la muerte súbita cardiaca …